BioCentury | Dec 9, 2011
Financial News

Tissue Regenix plans to raise L25M in placing

...The offering is subject to shareholder approval at a Dec. 28 general meeting. The company's dCell Vascular Patch...
BioCentury | May 23, 2011
Clinical News

DCell Vascular Patch musculoskeletal data

...evaluable patients ages 47-78 who underwent surgical repair of their peripheral arteries showed that the dCell Vascular Patch...
...flow in 17 patients at 1 year post-surgery. No significant adverse events were reported. The dCell Vascular Patch...
...approval in Europe for vascular tissue repair. Tissue Regenix Group plc (LSE:TRX), York, U.K. Product: DCell Vascular Patch...
BioCentury | Aug 16, 2010
Clinical News

dCell Vascular Patch regulatory update

...Tissue Regenix received CE Mark approval in Europe for its dCell Vascular Patch for vascular tissue repair. dCell... dCell is an acellular replacement product. Tissue Regenix Group plc (LSE:TRX), Leeds, U.K. Product: dCell Vascular Patch...
BioCentury | Jul 5, 2010
Company News

Tissue Regenix Ltd., Oxeco deal

...51.4% of the combined company. Tissue Regenix is developing acellular tissue repair products, including the dCell Vascular Patch...
Items per page:
1 - 4 of 4